AngioDynamics, Inc. (ANGO)
11.40
-0.12
(-1.04%)
USD |
NASDAQ |
Oct 12, 11:16
AngioDynamics Free Cash Flow (Quarterly) : -18.48M for Aug. 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | -18.48M |
| May 31, 2026 | 16.18M |
| February 28, 2026 | -4.617M |
| November 30, 2025 | 3.04M |
| August 31, 2025 | -17.46M |
| May 31, 2025 | 15.51M |
| February 28, 2025 | -16.35M |
| November 30, 2024 | 0.512M |
| August 31, 2024 | -20.66M |
| May 31, 2024 | -0.58M |
| February 29, 2024 | -16.38M |
| November 30, 2023 | 4.712M |
| August 31, 2023 | -26.69M |
| May 31, 2023 | 10.26M |
| February 28, 2023 | 0.164M |
| November 30, 2022 | 6.713M |
| August 31, 2022 | -26.80M |
| May 31, 2022 | -3.889M |
| February 28, 2022 | -9.897M |
| November 30, 2021 | 0.81M |
| August 31, 2021 | -9.925M |
| May 31, 2021 | 3.055M |
| February 28, 2021 | 4.489M |
| November 30, 2020 | 10.09M |
| August 31, 2020 | -7.249M |
| Date | Value |
|---|---|
| May 31, 2020 | 2.401M |
| February 29, 2020 | -18.84M |
| November 30, 2019 | 3.114M |
| August 31, 2019 | -8.816M |
| May 31, 2019 | 24.20M |
| February 28, 2019 | 7.455M |
| November 30, 2018 | 12.22M |
| August 31, 2018 | -9.555M |
| May 31, 2018 | 23.03M |
| February 28, 2018 | 3.89M |
| November 30, 2017 | 9.444M |
| August 31, 2017 | 2.535M |
| May 31, 2017 | 18.25M |
| February 28, 2017 | 13.95M |
| November 30, 2016 | 13.58M |
| August 31, 2016 | 6.959M |
| May 31, 2016 | 14.84M |
| February 29, 2016 | 11.67M |
| November 30, 2015 | 9.154M |
| August 31, 2015 | 3.956M |
| May 31, 2015 | 9.555M |
| February 28, 2015 | 7.962M |
| November 30, 2014 | -4.662M |
| August 31, 2014 | 0.094M |
| May 31, 2014 | 6.083M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.279B |
| Globus Medical, Inc. | 176.57M |
| Penumbra, Inc. | 32.54M |
| Abbott Laboratories | 1.991B |
| Alphatec Holdings, Inc. | -1.582M |